Effectiveness of Exercise After an ICD
E-ICD
Clinical Effectiveness of Exercise After an ICD (E-ICD)
1 other identifier
interventional
210
1 country
1
Brief Summary
This study will test an exercise intervention (E-ICD) following an implantable cardioverter defibrillator.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2018
CompletedFirst Posted
Study publicly available on registry
June 1, 2018
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2029
April 23, 2026
July 1, 2025
4.2 years
May 21, 2018
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Daily activity
average steps/day measured on Step Watch activity monitor
Baseline, 3, 6, and 12 months
Secondary Outcomes (5)
General Health
Baseline, 3, 6, and 12 months
Mobility
Baseline, 3, 6, and 12 months
Self-Efficacy for Walking
Baseline, 3, 6, and 12 months
ICD shock anxiety
Baseline, 3, 6, and 12 months
Depression
Baseline, 3, 6, and 12 months
Other Outcomes (1)
Long Term Maintenance
12 months
Study Arms (2)
E-ICD Intervention
EXPERIMENTALE-ICD Intervention over 3 months, consists of home walking to achieve the goal of 30 minutes on all or most of the days at moderate level intensity. E-ICD elements are: 1) exercise instructional DVD and manual, 2) exercise monitoring tools (Polar HR monitor, Borg scale, and exercise logs), and 3) telephone coaching by cardiac rehabilitation (CR) staff. Each participant receives an exercise prescription based on the ICD information using HR cut-offs, a minimum of 4 walking sessions/week will be prescribed. Exercise maintenance: At the 3 month conclusion of the E-ICD intervention, each patient will receive an exercise prescription based on the level they were able to achieve, with guidelines about increasing exercise to reach the target of 30 minutes/walking on all or most days over the ensuing 3 months.
Usual Care
NO INTERVENTIONUsual Care will receive treatment "as usual" from their health care clinicians with outcomes measured at baseline, 3, 6, and 12 months. Participants will not be discouraged from physical activity, but will be asked not to change their current level of activity for 6 months while in the study. Usual care involves ICD interrogation and follow-up every 3 months, measured either in-person or with home telephonic transmissions. Because participants in usual care may choose to participate in another exercise program, we will monitor those who participate in exercise programs and use the StepWatch monitor to quantify the amount and timing of physical activity. To control for group differences in attention, investigators will telephone usual care participants requesting information about health care utilization twice during the study at 3, 6, and 12 months.
Interventions
Eligibility Criteria
You may qualify if:
- ICD implantation for primary or secondary prevention of sudden cardiac arrest, -ability to read, speak and write English,-
- access to a reliable phone for 6 months after study entry,
- able to ambulate without assist devices for at least 5-10 minutes/day
- greater than 18 years of age.
You may not qualify if:
- current diagnosis of serious mental disorder,
- regular non-medical use of illicit drugs (opiates, cocaine, amphetamines, etc.), -unstable angina, myocardial infarction, ICD shock or heart surgery within previous 3 months
- pregnancy
- concurrent participation in an exercise program \> 5 days/week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Washington
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia M Dougherty, ARNP, PhD
University of Washington
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 21, 2018
First Posted
June 1, 2018
Study Start
May 1, 2025
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
June 30, 2029
Last Updated
April 23, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share